Concepedia

Timothy P. Hughes

TP

Statistics

Publications

307

Citations

45.8K

H-Index

86

Active since

1923

Affiliations

South Australia Pathology(Current)

The University of Adelaide

South Australian Health and Medical Research Institute

The University of Texas MD Anderson Cancer Center

Centre for Cancer Biology

Timothy P. Hughes is an author at South Australia Pathology specializing in medicine, chronic myeloid leukemia therapy, and molecular oncology.

ORCID

Publications per year

1923–2025

307

Publications

307

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Stephen G. O’Brien, François Guilhot, Richard A. Larson et al. · New England Journal of Medicine · 2003 · 3.6K citations · Full text

, , +10

Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Brian Druker, François Guilhot, Stephen G. O’Brien et al. · New England Journal of Medicine · 2006 · 3.5K citations · Full text

, , +13

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

Giuseppe Saglio, Dong‐Wook Kim, Surapol Issaragrisil et al. · New England Journal of Medicine · 2010 · 1.7K citations · Full text

, , +10

Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

Kathryn G. Roberts, Yongjin Li, Debbie Payne-Turner et al. · New England Journal of Medicine · 2014 · 1.4K citations · Full text

, , +17

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Andreas Hochhaus, Richard A. Larson, François Guilhot et al. · New England Journal of Medicine · 2017 · 1.3K citations · Full text

, , +12

1–5 of 307